Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2009
|
| gptkbp:approvedBy |
gptkb:European_Union
|
| gptkbp:ATCCode |
N03AF04
|
| gptkbp:brand |
gptkb:eslicarbazepine_acetate
|
| gptkbp:contraindication |
hypersensitivity to eslicarbazepine acetate
|
| gptkbp:developedBy |
gptkb:BIAL
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zebinix
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Eisai
|
| gptkbp:mechanismOfAction |
voltage-gated sodium channel blocker
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting dizziness headache rash somnolence |
| gptkbp:usedFor |
epilepsy
partial-onset seizures |
| gptkbp:bfsParent |
gptkb:BIAL
|
| gptkbp:bfsLayer |
7
|